Venus Remedies expands global reach with launch of Elores in Ecuador

12 Oct 2023 Evaluate

Venus Remedies has successfully launched Elores in Ecuador. This significant expansion follows the earlier launches of Elores in countries like Saudi Arabia, Myanmar, Oman, Tanzania, Ethiopia, and India, marking a momentous stride in the company's global growth. Additionally, the dossier has also been submitted in around 15 countries for getting the marketing authorisations. 

Elores, a cutting-edge antibiotic formulation, has been developed to combat multi-drug-resistant infections, making it a ground breaking addition to Venus Remedies Limited's product portfolio. It is a novel patented Antibiotic Adjuvant Entity containing a beta-lactam antibiotic, a beta-lactamase inhibitor, and an Antibiotic Resistance Breaker (ARB) that work synergistically to rescue antibiotic activity and suppress the emergence of resistance against the antibiotic. With its proven efficacy against a wide range of bacteria, Elores is set to revolutionise the treatment of infections and enhance the quality of healthcare in Ecuador. 

Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers.


Venus Remedies Share Price

760.00 -25.35 (-3.23%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×